News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Roka Furadada
Roka Furadada joins Hospital del Mar’s programme to humanise ICU
Healthcare
The startup Roka Furadada, with laboratories in the Barcelona Science Park, has donated a…
Telum_Treedom
Telum Therapeutics joins forces with Treedom to plant 100 trees
Climate change · Agrifood · Agriculture
This initiative aims to have a positive long term impact on the environment, economy and society by…
Equipo_Biolan
BIOLAN inaugurates its new facilities in the Bizkaia Technology Park in Zamudio, with the highest institutional representation headed by the Lehendakari Iñigo Urkullu
Industrial biotechnology
January 10th, in an event with numerous institutional representatives, headed by the…
Salud_Mental_biotecnología_AseBio
Innovation in mental health
Healthcare · Access to innovation · Innovative drugs · Advanced therapies
Innovation has enabled breakthroughs such as recent drugs for Alzheimer's disease, the use of…
AseBio-Investor-Day-2024
San Sebastián will host the AseBio Investor Day 2024, a meeting point for biotechnological innovation and global investors
Financing
The Investor Day, organized by AseBio and positioned as the benchmark meeting between investors and…
XRHealth
XRHealth Secures $6 Million in Funding Led By Asabys Partners and Welcomes NOVA Prime as a New Investor
Healthcare · Access to innovation · Financing
Funding will Support Development of AI Clinician, Using Spatial Computing.
Logo_25_aniversario_AseBio
AseBio celebrates 25 years: a quarter-century driving the biotechnology sector in Spain
Corporate
AseBio has been a key player in the journey taken over these 25 years by biotechnology in Spain,…
Glaucoma_biotecnología_AseBio
BCN HEALTH publishes a study evaluating the incidence and medical costs of glaucoma in Spain
Healthcare
The objective of this study was to analyze the impact of glaucoma in ambulatory centers and…
Salud_mental_biotecnología
ORYZON Announces Topline Results from Phase IIb PORTICO study of vafidemstat in Borderline Personality Disorder (BPD)
Healthcare
Results across all efficacy endpoints consistently favored vafidemstat over placebo. Global…